Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8238648rdf:typepubmed:Citationlld:pubmed
pubmed-article:8238648lifeskim:mentionsumls-concept:C1708335lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C0003467lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C0039659lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C0312418lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8238648lifeskim:mentionsumls-concept:C0036667lld:lifeskim
pubmed-article:8238648pubmed:issue12lld:pubmed
pubmed-article:8238648pubmed:dateCreated1993-12-17lld:pubmed
pubmed-article:8238648pubmed:abstractTextThe authors determined whether fear of anxiety symptoms mediates panicogenic responses to cholecystokinin tetrapeptide (CCK-4) in healthy subjects. Individuals with a preexisting high level of anxiety sensitivity (N = 10) experienced significantly more catastrophic cognitions and fear of somatic symptoms than did subjects with low (N = 9) or medium (N = 17) anxiety sensitivity, but they were not more susceptible to experiencing a panic attack. Thus, cognitive factors do not appear to be critical determinants of CCK-4-induced panic attacks.lld:pubmed
pubmed-article:8238648pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8238648pubmed:languageenglld:pubmed
pubmed-article:8238648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8238648pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8238648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8238648pubmed:statusMEDLINElld:pubmed
pubmed-article:8238648pubmed:monthDeclld:pubmed
pubmed-article:8238648pubmed:issn0002-953Xlld:pubmed
pubmed-article:8238648pubmed:authorpubmed-author:CoxB JBJlld:pubmed
pubmed-article:8238648pubmed:authorpubmed-author:BradwejnJJlld:pubmed
pubmed-article:8238648pubmed:authorpubmed-author:KoszyckiDDlld:pubmed
pubmed-article:8238648pubmed:issnTypePrintlld:pubmed
pubmed-article:8238648pubmed:volume150lld:pubmed
pubmed-article:8238648pubmed:ownerNLMlld:pubmed
pubmed-article:8238648pubmed:authorsCompleteYlld:pubmed
pubmed-article:8238648pubmed:pagination1881-3lld:pubmed
pubmed-article:8238648pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:meshHeadingpubmed-meshheading:8238648-...lld:pubmed
pubmed-article:8238648pubmed:year1993lld:pubmed
pubmed-article:8238648pubmed:articleTitleAnxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.lld:pubmed
pubmed-article:8238648pubmed:affiliationDepartment of Psychiatry, St. Mary's Hospital Center, Montreal, Que., Canada.lld:pubmed
pubmed-article:8238648pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8238648lld:pubmed